Quantum Biopharma Income Statement (2018-2026) | QNTM

Income Statement Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Research & Development (Quarter)
3.61M0.94M2.31M0.03M0.16M0.90M0.74M0.16M1.65M0.55M0.50M0.07M0.63M
Selling, General & Administrative (Quarter)
5.07M3.53M2.72M1.87M1.92M2.31M3.25M1.92M1.33M3.31M3.04M1.37M1.32M
Other Operating Expenses (Quarter)
4.00M1.18M4.82M3.28M0.18M0.25M0.19M0.18M0.42M0.99M1.14M0.94M1.02M
Operating Expenses (Quarter)
12.69M5.65M9.84M1.87M3.31M2.26M3.46M4.18M2.26M3.40M4.85M4.68M2.37M2.97M
Operating Income (Quarter)
-12.69M5.65M-9.84M-3.31M-2.26M-3.46M-4.18M-2.09M-3.40M-4.85M-4.68M-2.37M-2.97M
EBIT (Quarter)
-12.69M5.65M-9.84M-5.72M-3.31M-34.81M-2.26M-3.46M-4.18M-2.09M-3.40M-4.85M-4.68M-2.37M-2.97M
Non-operating items
Non Operating Investment Income (Quarter)
-0.29M-0.90M0.01M0.33M-0.02M-0.01M74.000.14M3.11M7.55M1.25M-23.82M6.95M
Interest & Investment Income (Quarter)
0.02M380.00-0.01M
Other Non Operating Income (Quarter)
3.02M0.08M-0.04M0.21M0.01M0.02M-0.01M0.06M0.29M0.11M-0.01M0.89M
Net income details
EBT (Quarter)
-12.71M5.63M-9.85M-5.72M-0.86M-34.81M-2.27M-3.45M-3.27M-5.46M-3.42M-4.97M-4.77M-2.30M-2.99M
Profit After Tax (Quarter)
-13.25M5.98M-9.96M-5.72M-1.06M-34.81M-9.96M-3.11M-3.83M-2.09M-8.58M-9.25M-5.32M-3.03M-13.56M
Net Income - Minority (Quarter)
0.19M0.43M0.62M0.16M0.68M-0.57M0.19M
Income from Non-Controlling Interests (Quarter)
-13.21M5.91M-9.96M-0.07M-18.16M-2.09M-3.35M-4.02M-24.37M-8.74M-9.77M4.75M-3.70M-13.75M
Other Income (Quarter)
-0.04M0.13M-0.07M0.02M-0.23M-0.23M-0.10M-0.00M0.08M0.12M
Income from Continuing Operations (Quarter)
-12.71M5.63M-9.85M-5.72M-0.86M-34.81M-2.27M-3.45M-3.27M-5.46M-3.42M-4.97M-4.77M-2.30M-2.99M
Consolidated Net Income (Quarter)
-0.45M-0.44M-9.85M-5.72M-0.86M-34.81M-2.27M-3.45M-3.27M-5.46M-3.42M-4.97M-4.77M-2.30M-2.99M
Income towards Parent Company (Quarter)
-0.45M-0.44M-9.85M-5.72M-1.06M-34.81M-2.08M-3.02M-3.83M-5.46M-3.26M-4.29M-5.34M-2.30M-2.80M
Net Income towards Common Stockholders (Quarter)
-0.45M-0.44M-9.85M-5.72M-1.06M-34.81M-2.08M-3.02M-3.83M-5.46M-3.26M-4.29M-5.34M-2.30M-2.80M
Additional items
EPS (Basic) (Quarter)
-0.04M-0.83-16.43-0.95M-0.18M-57.15-3.41-0.07-4.17-4.80-1.32-1.42-1.41-0.70-0.62
EPS (Diluted) (Quarter)
-0.82-0.83-16.53-0.15-1.76-57.17-3.41-0.07-4.17-4.80-1.32-1.42-1.41-0.61-622.83
Shares Outstanding (Quarter)
11.0013.000.54M0.54M5.008.000.60M0.60M6.006.000.61M0.61M41.68M0.92M1.14M2.47M3.02M3.80M3.29M4.49M
Shares Outstanding (Diluted) (Quarter)
0.55M0.56M0.54M0.54M0.60M0.60M0.60M0.60M39.23M0.60M0.61M0.61M41.68M0.92M1.14M2.47M3.02M3.80M3.80M0.00M
Shares Outstanding (Entity) (Quarter)
11.0013.000.62M5.008.000.60M0.60M6.006.000.61M0.62M47.41M0.92M1.14M2.71M3.47M3.82M3.89M4.49M
EBITDA (Quarter)
-12.69M5.65M-9.84M-5.72M-3.31M-34.81M-2.26M-3.46M-4.18M-2.09M-3.40M-4.85M-4.68M-2.37M-2.97M
Interest Expenses (Quarter)
0.02M0.02M0.02M0.02M-0.01M0.00M-380.000.00M0.01M0.01M0.01M0.00M0.03M0.12M0.09M-0.07M0.02M